Think GLP-1s Are Too Expensive for Your Health Plan? Cutting Them Might Hurt Your Bottom Line

A new study reveals that dropping coverage for weight-loss drugs like Ozempic could backfire—costing companies up to $866 per worker in lost productivity.

BY BRUCE CRUMLEY @BRUCEC_INC

Illustration: Inc.; Photos: Adobe Stock; Getty Images

A growing number of employers are moving to rein in the rising costs of providing staff medical insurance, with many deciding to no longer cover pricey GLP-1 drugs that are increasingly popular for losing weight. But while the reasoning behind that move is clear, a new study indicates it could wind up being even more expensive to businesses than continuing to underwrite workers’ prescriptions for medications like........

© Inc.com